Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07443059) titled 'A Study of Zovaglutide (ZT002 Injection) in Participants With Impaired Kidney Function and Healthy Participants' on Feb. 25.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Beijing QL Biopharmaceutical Co.,Ltd
Condition:
Overweight , Obesity
Intervention:
Drug: Zovaglutide
Drug: Zovaglutide
Drug: Zovaglutide
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: April 10, 2026
Target Sample Size: 40
Countries of Recruitment:
China
To know more, vi...